Sreelakshmi Kolli
Sreelakshmi Kolli's purchase track record
Sreelakshmi Kolli has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/30/2023 | ZBH | $120K | -5.1% | +3.7% | +12.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Zimmer Biomet Extends Exclusive Distribution Deal with Think Surgical. Zimmer Biomet has extended its exclusive distribution agreement with Think Surgical to supply the wireless TMINI miniature robotic system. The deal expands the company's reach in surgical robotics and aligns with its strategy of partnering with innovative technology providers. It follows strong Q2 results that benchmarked well against peers in the surgical equipment sector, reinforcing Zimmer Biomet’s competitive position within the S&P 500.
Transaction History
| ISRG | ▲ Buy | Option Exercise | 531 | $0 | 4/30/2026 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 739 | $0 | 4/25/2025 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 240 | $0 | 4/25/2024 | View on chart |
| ZBH | ▲ Buy | Open Market | 1,000 | $120K | 8/30/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Intuitive Surgical Prepares for Q3 Earnings Amid Growth and Competition
Intuitive Surgical is approaching its Q3 earnings release, with analysts noting continued double‑digit revenue growth and expanding procedure volumes. At the same time, new robotic competitors are entering the market, prompting discussion of the company's current valuation multiples. The stock has shown strong price momentum, reflected in a relatively high RSI and recent touches near its 200‑day moving average.
Intuitive Surgical Prepares for Q3 Earnings Amid Growth and Competition. Intuitive Surgical is approaching its Q3 earnings release, with analysts noting continued double‑digit revenue growth and expanding procedure volumes. At the same time, new robotic competitors are entering the market, prompting discussion of the company's current valuation multiples. The stock has shown strong price momentum, reflected in a relatively high RSI and recent touches near its 200‑day moving average.